BRIEF-Stemcells interim results show improvement in visual function and slowing of disease progression in phase I/II dry AMD trial

June 19 Thu Jun 19, 2014 8:32am EDT

June 19 (Reuters) - Stemcells <STEM.O:>

* Stemcells interim results show improvement in visual function and slowing of disease progression in phase i/ii dry amd trial

* Stemcells says interim results show 70 percent reduction in the rate of ga when comparedto the control eye

* Results show 65% reduction in rate of geographic atrophy in study eye compared to expected natural history of disease Source text for Eikon: Further company coverage: